Average Co-Inventor Count = 8.78
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vitae Pharmaceuticals, Inc. (66 from 84 patents)
2. Boehringer Ingelheim International Gmbh (14 from 1,533 patents)
3. Merck & Company, Inc. (4 from 4,759 patents)
4. Vitae Pharamceuticals, Inc. (1 from 1 patent)
5. Axontologic, Inc. (1 from 1 patent)
6. Vitae Pharmaceuticals, Inc./boehringer-ingelheim (1 from 1 patent)
74 patents:
1. 12312359 - Inhibitors of the menin-MLL interaction
2. 11739085 - Inhibitors of the menin-MLL interaction
3. 11535614 - Dihydropyrrolopyridine inhibitors of ROR-gamma
4. 11479557 - Inhibitors of the menin-MLL interaction
5. 11008340 - Modulators of ROR-gamma
6. 11001583 - Dihydropyrrolopyridine inhibitors of ROR-gamma
7. 10899758 - Inhibitors of the menin-MLL interaction
8. 10829481 - Benzimidazole derivatives as modulators of ROR-gamma
9. 10829448 - Substituted benzoimidazoles as modulators of ROR-γ
10. 10807980 - Dihydropyrrolopyridine inhibitors of ROR-gamma
11. 10683302 - Inhibitors of the menin-MLL interaction
12. 10654884 - Purine derivatives as CD73 inhibitors for the treatment of cancer
13. 10399976 - Dihydropyrrolopyridine inhibitors of ROR-gamma
14. 10336717 - Inhibitors of beta-secretase
15. 10301261 - Substituted indoles as modulators of ROR-gamma